Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFRT790M-Mutant NSCLCHa-Ram Park, Dae Seog Heo|Journal of Thoracic Oncology|2021Cited by 27